National Heart, Lung, and Blood Institute; Amended Notice of Meeting
---
identifier: "/us/fr/07-398"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Heart, Lung, and Blood Institute; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "07-398"
section_name: "National Heart, Lung, and Blood Institute; Amended Notice of Meeting"
positive_law: false
currency: "2007-01-31"
last_updated: "2007-01-31"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "07-398"
document_type: "notice"
publication_date: "2007-01-31"
agencies:
- "Health and Human Services Department"
- "National Institutes of Health"
fr_citation: "72 FR 4522"
fr_volume: 72
---
# National Heart, Lung, and Blood Institute; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National Heart, Lung, and Blood Institute Special Emphasis Panel, February 20, 2007, 2 p.m. to February 20, 2007, 3 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the *Federal Register* on January 12, 2007, FR 07-100.
The February 20, 2007 Meeting Panel Name was changed from VAD Technologies to Modified Hemoglobin Production. The meeting is closed to the public.
Dated: January 24, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.